TriSalus Life Sciences (TLSI) Non-Current Assets (2020 - 2026)

TriSalus Life Sciences' Non-Current Assets history runs 7 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• On a quarterly basis, Non-Current Assets fell 19.5% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $12.3 million, a 17.97% decrease from a year earlier, with the FY2025 full-year figure at $3.1 million, down 6.51% from the prior year.
• Non-Current Assets eased to $2.8 million in Q1 2026 per TLSI's latest filing, from $3.1 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $251.0 million in Q3 2022 and bottomed at $2.8 million in Q1 2026.
• The 5-year median for Non-Current Assets is $4.5 million (2024), against an average of $48.7 million.
• Across the five-year window, Non-Current Assets rose 0.38% in 2022 and plunged 98.2% in 2023, its largest moves.
• Year by year, Non-Current Assets stood at $4.8 million in 2022, then retreated by 21.86% to $3.7 million in 2023, then slipped by 11.62% to $3.3 million in 2024, then retreated by 6.51% to $3.1 million in 2025, then decreased by 7.97% to $2.8 million in 2026.
• Per Business Quant, the three latest TLSI Non-Current Assets figures stand at $2.8 million (Q1 2026), $3.1 million (Q4 2025), and $3.1 million (Q3 2025).